About Trialogix
We're transforming clinical trial design with intelligent, data-driven tools that accelerate protocol development and enhance study quality.
Trialogix is the industry's first platform for digitally native trial design—transforming protocol complexity into competitive advantage. We empower clinical development teams with AI-powered tools that enable faster, more precise protocol development while reducing operational risk and improving study outcomes.
Our Mission
Clinical trials are becoming increasingly complex, with longer protocols, more procedures, and higher operational costs. Traditional tools—Word documents, spreadsheets, and disconnected systems—create fragmented workflows, version control challenges, and costly delays.
Trialogix addresses these challenges by providing an intelligent workspace where every element of your protocol becomes structured, analyzable data. Our platform enables teams to design trials that are scientifically rigorous, operationally feasible, and built for success from day one.
Origins of Trialogix
Trialogix was developed by Jon Reifschneider and Dr. Pramod Singh, faculty members at Duke University, based on their research in AI-powered knowledge systems and clinical research optimization.
Recognizing the growing complexity challenges in clinical development, they built Trialogix to address the fundamental limitations of traditional protocol design tools. The platform emerged from years of collaboration with clinical operations teams, medical writers, and regulatory experts who needed better ways to manage protocol complexity and accelerate study startup.
Trialogix is proudly based in the Research Triangle Park area of North Carolina, home to one of the world's leading life sciences ecosystems. We're committed to advancing clinical research through intelligent technology that puts data-driven decision-making at the heart of protocol design.
